Treatment for Giant Cell Arteritis With Tocilizumab and 8 as Compared to 26 Weeks of Prednisone
Clinical trial NCT06833411 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06833411
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2030-08-01
- Enrollment
- 178
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.